Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Drosophila willistoni Ribosome biogenesis protein BOP1 homolog (GK22227), partial CSB-YP465483DMQ
CSB-EP465483DMQ
CSB-BP465483DMQ
CSB-MP465483DMQ
CSB-EP465483DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni tRNA (guanine-N (7)-)-methyltransferase CSB-YP465484DMQ
CSB-EP465484DMQ
CSB-BP465484DMQ
CSB-MP465484DMQ
CSB-EP465484DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (GK18052), partial CSB-YP465485DMQ
CSB-EP465485DMQ
CSB-BP465485DMQ
CSB-MP465485DMQ
CSB-EP465485DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni WD repeat-containing protein 55 homolog (GK12179), partial CSB-YP465486DMQ
CSB-EP465486DMQ
CSB-BP465486DMQ
CSB-MP465486DMQ
CSB-EP465486DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni cGMP-specific 3',5'-cyclic phosphodiesterase (Pde6), partial CSB-YP465487DMQ
CSB-EP465487DMQ
CSB-BP465487DMQ
CSB-MP465487DMQ
CSB-EP465487DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni Serine/threonine-protein phosphatase Pgam5, mitochondrial (Pgam5), partial CSB-YP465488DMQ
CSB-EP465488DMQ
CSB-BP465488DMQ
CSB-MP465488DMQ
CSB-EP465488DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni Eukaryotic translation initiation factor 3 subunit F-1 (eIF3-S5-1) CSB-YP465489DMQ
CSB-EP465489DMQ
CSB-BP465489DMQ
CSB-MP465489DMQ
CSB-EP465489DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila simulans Probable cytosolic Fe-S cluster assembly factor GD17698 (GD17698) CSB-YP465490DMJ
CSB-EP465490DMJ
CSB-BP465490DMJ
CSB-MP465490DMJ
CSB-EP465490DMJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Probable cGMP 3',5'-cyclic phosphodiesterase subunit delta (PrBP) CSB-YP465491DMR
CSB-EP465491DMR
CSB-BP465491DMR
CSB-MP465491DMR
CSB-EP465491DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Vitelline membrane protein Vm32E (Vm32E) CSB-YP465492DMR
CSB-EP465492DMR
CSB-BP465492DMR
CSB-MP465492DMR
CSB-EP465492DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Glutamyl-tRNA (Gln) amidotransferase subunit C, mitochondrial, partial CSB-YP465493DMR
CSB-EP465493DMR
CSB-BP465493DMR
CSB-MP465493DMR
CSB-EP465493DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Lissencephaly-1 homolog (Lis-1) CSB-YP465494DMR
CSB-EP465494DMR
CSB-BP465494DMR
CSB-MP465494DMR
CSB-EP465494DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Protein teflon (tef), partial CSB-YP465495DMR
CSB-EP465495DMR
CSB-BP465495DMR
CSB-MP465495DMR
CSB-EP465495DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Protein crossbronx-like (GE13821) CSB-YP465496DMR
CSB-EP465496DMR
CSB-BP465496DMR
CSB-MP465496DMR
CSB-EP465496DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Ribosome-releasing factor 2, mitochondrial (EF-G2), partial CSB-YP465497DMR
CSB-EP465497DMR
CSB-BP465497DMR
CSB-MP465497DMR
CSB-EP465497DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Eukaryotic translation initiation factor 3 subunit G-2 (eIF3-S4-2) CSB-YP465498DMR
CSB-EP465498DMR
CSB-BP465498DMR
CSB-MP465498DMR
CSB-EP465498DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba CDGSH iron-sulfur domain-containing protein 2 homolog (GE10465), partial CSB-YP465499DMR
CSB-EP465499DMR
CSB-BP465499DMR
CSB-MP465499DMR
CSB-EP465499DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba E3 UFM1-protein ligase 1 homolog (GE25823), partial CSB-YP465500DMR
CSB-EP465500DMR
CSB-BP465500DMR
CSB-MP465500DMR
CSB-EP465500DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Protein cereblon homolog (GE26004), partial CSB-YP465501DMR
CSB-EP465501DMR
CSB-BP465501DMR
CSB-MP465501DMR
CSB-EP465501DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (GE15286) CSB-YP465502DMR
CSB-EP465502DMR
CSB-BP465502DMR
CSB-MP465502DMR
CSB-EP465502DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>